This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Institute of Nuclear Energy Research. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taipei, TW (2012)
- Taoyuan, TW (2017)
Company Filing History:
Years Active: 2012-2017
Title: Wei-Hsi Chen: Innovator in Alzheimer's Disease Diagnosis
Introduction
Wei-Hsi Chen is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. His innovative work has the potential to impact the way this condition is diagnosed and understood.
Latest Patents
Wei-Hsi Chen holds a patent for the use of N-(4-isopropylphenyl)-5-amino-isoindoline. This invention relates to a novel application of this compound for diagnosing Alzheimer's disease and quantifying amyloid in the brain. His patent represents a significant advancement in the medical field, offering new avenues for research and treatment.
Career Highlights
Wei-Hsi Chen is affiliated with the Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. His work at this esteemed institution has allowed him to focus on innovative research that bridges the gap between nuclear energy and medical applications.
Collaborations
Some of his notable coworkers include Wan-I Kuo and Jian-Hua Zhao. Their collaborative efforts contribute to the advancement of research in the field of medical diagnostics.
Conclusion
Wei-Hsi Chen's contributions to the diagnosis of Alzheimer's disease through his innovative patent highlight the importance of research and development in medical science. His work exemplifies the potential of inventions to improve healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile